Immunotherapy for Head and Neck Cancer Treatment
1 vistas
• 07/02/23
0
0
Empotrar
administrator
Suscriptores
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios